Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Key Technical Services for Drug R&D

Deeply integrate R&D experience, constantly climb the peak of R&D technology, and build an integrated innovation service platform for new drug R&D

Key Technical Services for Drug R&D

Technology plays a critical role in drug development and the R&D value chain by revolutionizing clinical trials and decreasing the failure rate. Medicilon has a series of key technology service platforms for drug R&D, such as cytokine and biomarker detection service platform, Met-ID platform, druggability research platform, and chemical process reaction safety assessment experiment platform, etc.

Cytokine and Biomarker Detection Platform.webp

Cytokine and Biomarker Detection

Medicilon can provide detection services for cytokines and biomarkers for the majority of pharmaceutical R&D personnel. Its biological analysis department has complete infrastructure and advanced instruments and equipment. It has high-end technology platforms such as flow CBA, MSD and Luminex systems, which can detect various single plex or multiple forms of cytokines and biomarkers.

Learn more

Flow Cytometry Technology Platform.webp

Flow Cytometry Technology

Medicilon's streaming technology platform is committed to exploring and insight into the progress of tumor immune targeted therapy drugs, and providing accurate and reliable test prediction data in the early development stage. Our team has rich experience in experimental operation, streaming method development and data analysis, and every scientists could be independently responsible for the project. The platform is equipped with powerful flow cytometers of different brands such as BD and Bio-Rad.

Learn more

Metabolite Identification (MetID) Service.webp

Metabolite Identification (MetID) Service

The MetID team of Medicilon is composed of experienced scientists. We provide fast and reliable in vivo and in vitro MetID and reactive metabolite capture services. We also support new drug screening and domestic and foreign IND filings. Since the establishment of MetID team, Medicilon has successfully completed a large number of different types of research projects for the clients, including the challenging peptide MetID research.

Learn more

Drug Forming Research.webp

Drug Forming Research

Medicipia provides research services for compound druggability evaluation. The evaluation indicators involve in-vitro pharmacokinetic research, bioavailability research, early safety evaluation research, etc., assisting pharmaceutical companies to select candidate compounds with better druggability prospects and carry out further development, or early termination of research and development of drugs with poor druggability prospects.

Learn more

Safety Assessment Lab of Process Chemistry.webp

Safety Assessment Lab of Process Chemistry

In the research and development process of innovative drugs, the chemical process research of drugs plays a pivotal role. During the synthesis process to the scale up process in the laboratory, it is not only about output, but also various errors and risks. Therefore, in the development of innovative drugs, the assessment of the safety of chemical processes and equipment is extremely important.

Learn more

Process Department Solid Form Screening.webp

Process Department Solid Form Screening

The solid screening platform of Medicilon process department strictly complies with the registration regulations and regulatory requirements of China NMPA, FDA and other regulatory authorities, studies and controls the solid morphology of drug molecules in API and preparations, and can formulate the optimal screening strategy according to the material characteristics, including but not limited to crystallization method, solvent selection and ion selection.

Learn more

Return